Trigeminal Ganglion Metastasis of Renal Clear Cell Carcinoma: Cases Report and Review of the Literature.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 22 03 2019
revised: 26 04 2019
accepted: 27 04 2019
pubmed: 7 5 2019
medline: 21 1 2020
entrez: 7 5 2019
Statut: ppublish

Résumé

The trigeminal ganglion is an atypical site for metastasis, especially for renal clear cell carcinoma. We report 2 clinical cases of a 66-year-old man and a 58-year-old man with trigeminal symptoms. Both patients had a history of renal clear cell (RCC) that was considered to be cured at 6 and 9 years, respectively. Brain magnetic resonance imaging (MRI) showed a trigeminal ganglion lesion with increased gadolinium enhancement associated with petrous apex erosion. The main diagnostic hypothesis based on MRI was trigeminal schwannoma for both patients. One patient underwent subtotal removal, the other a biopsy. Histologic examinations resulted in the diagnosis of RCC metastasis. Body computed tomography revealed pancreatic metastasis for both but no renal recurrence. The patients were treated by local radiotherapy, and 1 of the patients had associated chemotherapy. We added to these clinical cases a literature review of skull base metastasis of RCC. Trigeminal ganglion metastasis of RCC is very rare and can persist until 10 years after the first RCC diagnosis. It seems that the best treatment is surgical removal. To date, the role of local radiotherapy is not demonstrated, and the prognosis seems to be poor. In the case of trigeminal symptoms, rapid tumoral growth on brain MRI, or a history of RCC, we think that a body computed tomography should be performed, and surgery should be considered.

Sections du résumé

BACKGROUND BACKGROUND
The trigeminal ganglion is an atypical site for metastasis, especially for renal clear cell carcinoma.
CASE DESCRIPTION METHODS
We report 2 clinical cases of a 66-year-old man and a 58-year-old man with trigeminal symptoms. Both patients had a history of renal clear cell (RCC) that was considered to be cured at 6 and 9 years, respectively. Brain magnetic resonance imaging (MRI) showed a trigeminal ganglion lesion with increased gadolinium enhancement associated with petrous apex erosion. The main diagnostic hypothesis based on MRI was trigeminal schwannoma for both patients. One patient underwent subtotal removal, the other a biopsy. Histologic examinations resulted in the diagnosis of RCC metastasis. Body computed tomography revealed pancreatic metastasis for both but no renal recurrence. The patients were treated by local radiotherapy, and 1 of the patients had associated chemotherapy. We added to these clinical cases a literature review of skull base metastasis of RCC. Trigeminal ganglion metastasis of RCC is very rare and can persist until 10 years after the first RCC diagnosis. It seems that the best treatment is surgical removal. To date, the role of local radiotherapy is not demonstrated, and the prognosis seems to be poor.
CONCLUSIONS CONCLUSIONS
In the case of trigeminal symptoms, rapid tumoral growth on brain MRI, or a history of RCC, we think that a body computed tomography should be performed, and surgery should be considered.

Identifiants

pubmed: 31059855
pii: S1878-8750(19)31227-6
doi: 10.1016/j.wneu.2019.04.230
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

541-546

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Céline Salaud (C)

Department of Neurotrauma/Neurosurgery, Nantes University Hospital, Saint-Herblain, France. Electronic address: celine.salaud@chu-nantes.fr.

Vincent Roualdes (V)

Department of Neurotrauma/Neurosurgery, Nantes University Hospital, Saint-Herblain, France.

François Thillays (F)

Department of Radiotherapy, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.

Stéphane André Martin (SA)

Department of Neurotrauma/Neurosurgery, Nantes University Hospital, Saint-Herblain, France.

Kévin Buffenoir (K)

Department of Neurotrauma/Neurosurgery, Nantes University Hospital, Saint-Herblain, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH